Morgan Stanley’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134M | Buy |
|
|||||
|
2025
Q1 | $73.7M | Sell |
|
|||||
|
2024
Q4 | $88.1M | Buy |
|
|||||
|
2024
Q3 | $61.2M | Sell |
|
|||||
|
2024
Q2 | $98.5M | Buy |
|
|||||
|
2024
Q1 | $88.2M | Sell |
|
|||||
|
2023
Q4 | $181M | Buy |
|
|||||
|
2023
Q3 | $67.4M | Sell |
|
|||||
|
2023
Q2 | $76.8M | Sell |
|
|||||
|
2023
Q1 | $86.4M | Sell |
|
|||||
|
2022
Q4 | $113M | Buy |
|
|||||
|
2022
Q3 | $69.4M | Sell |
|
|||||
|
2022
Q2 | $86.5M | Buy |
|
|||||
|
2022
Q1 | $50.3M | Buy |
|
|||||
|
2021
Q4 | $38M | Sell |
|
|||||
|
2021
Q3 | $58.6M | Buy |
|
|||||
|
2021
Q2 | $61.8M | Sell |
|
|||||
|
2021
Q1 | $59M | Buy |
|
|||||
|
2020
Q4 | $57.9M | Buy |
|
|||||
|
2020
Q3 | $39.6M | Sell |
|
|||||
|
2020
Q2 | $70.6M | Buy |
|
|||||
|
2020
Q1 | $46.2M | Buy |
|
|||||
|
2019
Q4 | $38.7M | Sell |
|
|||||
|
2019
Q3 | $31.8M | Sell |
|
|||||
|
2019
Q2 | $47.7M | Buy |
|
|||||
|
2019
Q1 | $30.1M | Sell |
|
|||||
|
2018
Q4 | $50.7M | Buy |
|
|||||
|
2018
Q3 | $43.2M | Sell |
|
|||||
|
2018
Q2 | $55.3M | Buy |
|
|||||
|
2018
Q1 | $37.6M | Sell |
|
|||||
|
2017
Q4 | $42.2M | Buy |
|
|||||
|
2017
Q3 | $39.4M | Sell |
|
|||||
|
2017
Q2 | $41.7M | Buy |
|
|||||
|
2017
Q1 | $35.8M | Buy |
|
|||||
|
2016
Q4 | $30.7M | Sell |
|
|||||
|
2016
Q3 | $37.3M | Buy |
|
|||||
|
2016
Q2 | $24.7M | Sell |
|
|||||
|
2016
Q1 | $30.3M | Buy |
|
|||||
|
2015
Q4 | $25.1M | Sell |
|
|||||
|
2015
Q3 | $38.3M | Buy |
|
|||||
|
2015
Q2 | $38.3M | Sell |
|
|||||
|
2015
Q1 | $41.7M | Sell |
|
|||||
|
2014
Q4 | $32.3M | Sell |
|
|||||
|
2014
Q3 | $34.2M | Buy |
|
|||||
|
2014
Q2 | $24.4M | Buy |
|
|||||
|
2014
Q1 | $24M | Sell |
|
|||||
|
2013
Q4 | $26.7M | Buy |
|
|||||
|
2013
Q3 | $24.4M | Buy |
|
|||||
|
2013
Q2 | $6.66M | Buy |
|